Trailing-twelve-month (TTM) revenue is $3.92 Billion with a year-over-year growth of (0.84%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-10-31 | $1,036,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-04 |
| Q3 FY2026Period ended 2026-01-31 | $1,056,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-04 |
| Q4 FY2026Period ended 2026-04-30 | $912,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-12 |
| Q1 FY2027Period ended 2026-07-31 | $911,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-02 |
| TTM revenue | $3,915,000,000 |
Current P/S: $12,400,037,981 market capitalization ÷ $3,915,000,000 TTM revenue = 3.17x.
Market capitalization source: FMP quote. Quote observed 2026-09-10T20:00:03.000Z. Latest revenue period ended 2026-07-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-07-31): $911.00M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-11T02:31:05.573Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-04-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-04-30 · USD | FY20222022-04-30 · USD | FY20232023-04-30 · USD | FY20242024-04-30 · USD | FY20252025-04-30 · USD | FY20262026-04-30 · USD |
|---|---|---|---|---|---|---|
| Non-branded and bulk | $58M | $61M | $88M | $87M | $102M | $33M |
| Ready-to-Drink | N/A | N/A | $509M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-04-30 · USD | FY20222022-04-30 · USD | FY20232023-04-30 · USD | FY20242024-04-30 · USD | FY20252025-04-30 · USD | FY20262026-04-30 · USD |
|---|---|---|---|---|---|---|
| AUSTRALIA | $209M | $219M | $221M | $204M | $199M | $200M |
| GERMANY | $206M | $228M | $239M | $263M |
$3.92B
$3.92 Billion
(0.84%)
vs. $3.95B a year ago (TTM)
+1.61%
5 Year compound annual growth rate
1 Year
(0.84%)
3 Year
(2.77%)
5 Year
+1.61%
10 Year
+2.52%
15 Year
+1.65%
20 Year
+3.32%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $3.93B | ($47.00M) | (1.18%) |
| 2025 | $3.98B | ($203.00M) | (4.86%) |
| 2024 | $4.18B | ($50.00M) | (1.18%) |
| 2023 | $4.23B | +$295.00M | +7.50% |
| 2022 | $3.93B | +$472.00M | +13.64% |
| 2021 |
TTM Growth
(0.84%)
3-Year CAGR
(2.77%)
5-Year CAGR
+1.61%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-11T02:31:05.573Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-04-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $491M |
| $542M |
| Rest of portfolio | $64M | $70M | $91M | $146M | $292M | $201M |
|---|
| Tequila | $299M | $364M | $320M | $306M | $262M | $251M |
|---|
| Vodka | $90M | $109M | $99M | $82M | N/A | N/A |
|---|
| Whiskey | $2.7B | $3.1B | $2.9B | $2.8B | $2.8B | $2.9B |
|---|
| Wine | $206M | $219M | $206M | $205M | N/A | N/A |
|---|
| $248M |
| MEXICO | $150M | $178M | $244M | $290M | $267M | $319M |
|---|
| Other Countries | $943M | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B |
|---|
| UNITED KINGDOM | $205M | $218M | $207M | $185M | $174M | $164M |
|---|
| UNITED STATES | $1.7B | $1.9B | $2.0B | $1.9B | $1.8B | $1.6B |
|---|
| $3.46B |
| +$98.00M |
| +2.91% |
| 2020 | $3.36B | +$39.00M | +1.17% |
| 2019 | $3.32B | +$76.00M | +2.34% |
| 2018 | $3.25B | +$254.00M | +8.48% |
| 2017 | $2.99B | ($95.00M) | (3.08%) |
